Direct hyperplasia does not enhance the kinetics of liver repopulation in a new model of hepatocyte transplantation in the rat

Journal of Hepatology

Volumn 31, Issue 2, 1999, Pages 354-359

  Pani, Paolo ^a   Laconi, Sergio ^a   Pillai, Sara ^a   Scintu, Franca ^a   Curreli, Francesca ^a   Shafritz, David A ^c   Laconi, Ezio ^a,b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b Ospedale Oncologico A Businco   (Italy)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Hepatocyte transplantation; Liver repopulation; Mitogen; Mitoinhibition; Pyrrolizidine alkaloids; Retrorsine

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; LEAD NITRATE; MITOGENIC AGENT; PYRROLIZIDINE ALKALOID; RETRORSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; DNA CONTENT; ENZYME DEFICIENCY; FEMALE; KINETICS; LIVER CELL; LIVER WEIGHT; MALE; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032806948     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80235-9     Document Type: Article

References (24)

1. Starzl TE, Demetris AJ, Van Thiel D. Liver transplantation. N Engl J Med. 321:1989;1014-1023.
2. Matas AJ, Sutherland DER, Steffers MW, Mauer SM, Lowe A, Simmons RL, et al. Hepatocellular transplantation for metabolic deficiencies: decrease of plasma bilirubin in Gunn rats. Science. 192:1976;892-894.
3. Gupta S, Roy Chowdhury J. Hepatocyte transplantation: back to the future. Hepatology. 15:1992;156-162.
4. Kay MA, Woo SLC. Gene therapy for metabolic disorders. Trends Genet. 10:1994;253-257.
5. Grossmann M, Raper SE, Kozarsky K, Stein EA, Engelhardt JF, Muller D, et al. Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat Genet. 6:1994;335-341.
6. Rhim JA, Sandgren EP, Degen JL, Palmiter RD, Brinster RL. Replacement of diseased mouse liver by hepatic cell transplantation. Science. 263:1994;1149-1152.
7. Overturf K, Al-Dhalimy M, Tanguay R, Brantly M, Ou C-N, Finegold M, et al. Hepatocyte corrected by gene therapy are selected in vivo in a murine model of hereditary tyrosinaemia type I. Nat Genet. 12:1996;266-273.
8. Wilson JM. Round two for liver gene therapy. Nat Genet. 12:1996;232-233.
9. Laconi E, Sarma DSR, Pani P. Transplantation of normal hepatocytes modulates the development of chronic liver lesions induced by a pyrrolizidine alkaloid, lasiocarpine. Carcinogenesis. 16:1995;139-142.
10. McLean E. The toxic actions of pyrrolizidine (senecio) alkaloids. Pharmacol Rev. 22:1970;429.
11. Mattocks AR. Chemistry and Toxicology of Pyrrolizidine Alkaloids. 1986;Academic Press, Orlando, FL.
12. Peterson JE. Effects of the pyrrolizidine alkaloid lasiocarpine-Noxide on nuclear and cell division in the liver of rats. J Pathol Bacteriol. 89:1965;153-171.
13. Jago MV. The development of the hepatic megalocytosis of chronic pyrrolizidine alkaloid poisoning. Am J Pathol. 56:1969;405-422.
14. Samuel A, Jago MV. Localization in the cell cycle of the antimitotic action of the pyrrolizidine alkaloid, lasiocarpine and of its metabolite, dehydroheliotridine. Chem Biol Interact. 10:1975;185-197.
15. Hayes MA, Roberts E, Farber E. Initiation and selection of resistant hepatocyte nodules in rats given the pyrrolizidine alkaloids lasiocarpine and senecionine. Cancer Res. 45:1985;3726-3734.
16. Pani P, Sarma DSR, Yusuf A, Curreli F, Diana S, Pillai S, et al. Effect of retrorsine, a pyrrolizidine alkaloid, on rat liver DNA synthesis induced by 2/3 partial hepatectomy. [abstract] FASEB J. 11:1997;227A.
17. Laconi E, Oren R, Mukhopadhyay DK, Hurston E, Laconi S, Pani P, et al. Long term, near total liver replacement by transplantation of isolated hepatocytes in rats treated with retrorsine. Am J Pathol. 1998;. in press.
18. Columbano A, Ledda GM, Sirigu P, Perra T, Pani P. Liver cell proliferation induced by a single dose of lead nitrate. Am J Pathol. 110:1983;83-86.
19. Thompson NL, Hixson DC, Callavan H, Panzica M, Flanagan D, Faris RA, et al. A Fischer rat substrain deficient in dipeptidyl peptidase IV activity makes normal steady-state RNA levels and an altered protein. Use as a liver-cell transplantation model. Biochem J. 273:1991;497-502.
20. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol. 13:1976;29-83.
21. Laconi E, Yusuf A, Jahangir AR, Laconi S, Rao PM, Rajalakshmi S, et al. Transient inhibition by orotic acid does not abolish the in vivo response of rat hepatocytes to a direct mitogen, lead nitrate. J Hepatol. 26:1997;203-208.
22. Bucher NLR, Swaffield MN. The rate of incorporation of labeled thymidine into the deoxyribonucleic acid of regenerating rat liver in relation to the amount of liver excised. Cancer Res. 240:1964;1611-1625.
23. Coni P, Pichiri-Coni G, Curto M, Simbula G, Giacomini L, Sarma DSR, et al. Different effects of regenerative and direct mitogenic stimuli on the growth of initiated cells in the resistant hepatocyte model. Jpn J Cancer Res. 84:1993;501-507.
24. Columbano A, Ledda-Columbano GM, Coni P, Faa G, Liguori C, Santacruz G, et al. Occurrence of cell death (apoptosis) during the involution of liver hyperplasia. Lab Invest. 52:1985;670-675.